CSPG4 and melanoma: Whilst cross-linking of NIP IgE (positive control) by its specific multimeric antigen (NIP-BSA) triggered significant degranulation, incubation with CSPG4 IgE with sera from healthy volunteers (n = 16) and patients with melanoma (n = 15) triggered no degranulation above background (Fig. 8a).